RxSight to Present at the J.P. Morgan Healthcare Conference
29 December 2021 - 8:05AM
RxSight, Inc.
(NASDAQ: RXST), an ophthalmic
medical device company dedicated to improving the vision of
patients following cataract surgery, today announced plans to
participate in the upcoming virtual J.P. Morgan Healthcare
Conference.
RxSight® management is scheduled to present Thursday, January
13, 2022, at 6:45am PT / 9:45am ET. Interested parties may access a
live and archived webcast of the presentation on the “Investors”
section of the company’s website at:
https://investors.rxsight.com/.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight can be found at www.rxsight.com.
Investor Relations Contact:Philip Taylor
Gilmartin Group415.937.5406IR@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024